Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bio-Path Holdings (BPTH)
NASDAQ:BPTH
Bio-Path Holdings (BPTH) Stock Price & Analysis
332 Followers
BPTH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.35 - $3.58
Previous Close$0.38
Volume31.66K
Average Volume (3M)353.34K
Market Cap
$4.33M
Enterprise ValueN/A
Total Cash (Recent Filing)$3.40M
Total Debt (Recent Filing)$168.00K
Price to Earnings (P/E)-0.2
Beta0.71
Next Earnings
Nov 17, 2023EPS Estimate
-$0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.24
Shares Outstanding11,460,164
10 Day Avg. Volume61,946
30 Day Avg. Volume353,340
Standard Deviation0.92
R-Squared0.00643
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.93
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$12.00Price Target Upside3043.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bio-Path Holdings News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BPTH FAQ
What was Bio-Path Holdings’s price range in the past 12 months?
Bio-Path Holdings lowest stock price was $0.35 and its highest was $3.58 in the past 12 months.
What is Bio-Path Holdings’s market cap?
Currently, no data Available
When is Bio-Path Holdings’s upcoming earnings report date?
Bio-Path Holdings’s upcoming earnings report date is Nov 17, 2023 which is in 55 days.
How were Bio-Path Holdings’s earnings last quarter?
Bio-Path Holdings released its earnings results on Aug 15, 2023. The company reported -$0.53 earnings per share for the quarter, missing the consensus estimate of -$0.52 by -$0.01.
Is Bio-Path Holdings overvalued?
According to Wall Street analysts Bio-Path Holdings’s price is currently Undervalued.
Does Bio-Path Holdings pay dividends?
Bio-Path Holdings does not currently pay dividends.
What is Bio-Path Holdings’s EPS estimate?
Bio-Path Holdings’s EPS estimate is -$0.34.
How many shares outstanding does Bio-Path Holdings have?
Bio-Path Holdings has 11,460,164 shares outstanding.
What happened to Bio-Path Holdings’s price movement after its last earnings report?
Bio-Path Holdings reported an EPS of -$0.53 in its last earnings report, missing expectations of -$0.52. Following the earnings report the stock price went down -11.628%.
Which hedge fund is a major shareholder of Bio-Path Holdings?
Currently, no hedge funds are holding shares in BPTH
---
Bio-Path Holdings Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.00 (3043.83% Upside)
$12.00 (3043.83% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 5.7%
Last 30 Days ▼ 5.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-89.45%
12-Months-Change
Fundamentals
Return on Equity
-138.48%
Trailing 12-Months
Asset Growth
-68.95%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Bio-Path Holdings
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline include Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
---
Top 5 ETFs holding BPTH
Vanguard Total Stock Market ETF
$49.98K
iShares Core S&P Total U.S. Stock Market ETF
$98.98
Up to five ETFs with an Outperform Smart Score that hold BPTH. The ETFs are listed according to market value of BPTH within the ETF
---